Cancer Organoids as reliable disease models to drive clinical development of novel therapies

被引:2
|
作者
Giovanni Blandino [1 ]
Ronit Satchi-Fainaro [2 ]
Ingeborg Tinhofer [3 ]
Giovanni Tonon [4 ]
Sarah C. Heilshorn [5 ]
Yong-Jun Kwon [6 ]
Ana Pestana [3 ]
Carlotta Frascolla [1 ]
Luca Pompili [1 ]
Aurora Puce [7 ]
Sara Iachettini [1 ]
Annalisa Tocci [8 ]
Sofia Karkampouna [9 ]
Marianna Kruithof-de Julio [9 ]
Piera Tocci [10 ]
Nicla Porciello [8 ]
Klizia Maccaroni [7 ]
Daniela Rutigliano [1 ]
Xiling Shen [11 ]
Gennaro Ciliberto [12 ]
机构
[1] IRCCS Regina Elena National Cancer Institute,Translational Research Unit
[2] Tel Aviv University,Deapartment of Physiology and Pharmacology
[3] Charité University Medicin,Department of Radiooncology and Radiotherapy
[4] IRCCS San Raffaele Scientific Institute,Center of Omics Sciences
[5] Stanford University,Department of Materials Science and Engineering
[6] Luxembourg Institute of Health,Cellular Network and Molecular Therapeutic Target Unit
[7] IRCCS Regina Elena National Cancer Institute,Tumor of Immunology and Immunotherapy Unit
[8] IRCCS Regina Elena National Cancer Institute,Department for BioMedical Research
[9] University of Bern,Unit of Preclinical Models and New Therapeutic Agents
[10] IRCCS Regina Elena National Cancer Institute,GI Medical Oncology
[11] MD Anderson Cancer Center,Scientific Direction
[12] Terasaki Institute of Biomedical Innovation,undefined
[13] IRCCS Regina Elena National Cancer Institute,undefined
关键词
Organoid; Precision medicine; Patient-derived 3D culture model; Targeted therapy; Preclinical models; Cancer spheroid;
D O I
10.1186/s13046-024-03258-7
中图分类号
学科分类号
摘要
On September 23–24 (2024) the 6th Workshop IRE on Translational Oncology, titled “Cancer Organoids as Reliable Disease Models to Drive Clinical Development of Novel Therapies,” took place at the IRCCS Regina Elena Cancer Institute in Rome. This prominent international conference focused on tumor organoids, bringing together leading experts from around the world.
引用
收藏
相关论文
共 50 条
  • [31] Development of novel therapies for Huntington's disease: hope and challenge
    Zheng-hong Qin
    Jin Wang
    Zhen-lun Gu
    Acta Pharmacologica Sinica, 2005, 26 : 129 - 142
  • [32] Biomarkers in the development of novel disease-modifying therapies for osteoarthritis
    Parsons, Stephanie
    Alesci, Salvatore
    Feuerstein, Giora
    Wang, Jingsong
    BIOMARKERS IN MEDICINE, 2008, 2 (06) : 587 - 602
  • [33] Animal models of corneal endothelial dysfunction to facilitate development of novel therapies
    Park, Sangwan
    Leonard, Brian C.
    Raghunathan, Vijay Krishna
    Kim, Soohyun
    Li, Jennifer Y.
    Mannis, Mark J.
    Murphy, Christopher J.
    Thomasy, Sara M.
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (15)
  • [34] Three-Dimensional Cultures of Prostatic Cells: Tissue Models for the Development of Novel Anti-Cancer Therapies
    Kim C. O'Connor
    Pharmaceutical Research, 1999, 16 : 486 - 493
  • [35] Three-dimensional cultures of prostatic cells: Tissue models for the development of novel anti-cancer therapies
    O'Connor, KC
    PHARMACEUTICAL RESEARCH, 1999, 16 (04) : 486 - 493
  • [36] Organoids: development and applications in disease models, drug discovery, precision medicine, and regenerative medicine
    Yao, Qigu
    Cheng, Sheng
    Pan, Qiaoling
    Yu, Jiong
    Cao, Guoqiang
    Li, Lanjuan
    Cao, Hongcui
    MEDCOMM, 2024, 5 (10):
  • [37] Novel In Vitro Cancer Models for Optimizing Anti-EGFR Therapies
    Napolitano, Stefania
    Ciardiello, Fortunato
    CLINICAL CANCER RESEARCH, 2018, 24 (04) : 727 - 729
  • [38] Breast cancer therapies in development - A review of their pharmacology and clinical potential
    deValeriola, D
    Awada, A
    Roy, JA
    DiLeo, A
    Biganzoli, L
    Piccart, M
    DRUGS, 1997, 54 (03) : 385 - 413
  • [39] Breast cancer immune microenvironment: from pre-clinical models to clinical therapies
    Brooke E. Wilson
    Chiara Gorrini
    David W. Cescon
    Breast Cancer Research and Treatment, 2022, 191 : 257 - 267
  • [40] Breast cancer immune microenvironment: from pre-clinical models to clinical therapies
    Wilson, Brooke E.
    Gorrini, Chiara
    Cescon, David W.
    BREAST CANCER RESEARCH AND TREATMENT, 2022, 191 (02) : 257 - 267